Breathe Well Live Well
|
South Carolina adopts positive coverage of Aerocrine's FeNO testing in …
CisionWire (press release) Physicians use FeNO to assess eosinophilic airway inflammation, the primary underlying abnormality that affects the airways of individuals who have asthma. NIOX MINO is the only product of its kind currently on the market for assessing FeNO. |
View full post on asthma – Google News
|
Mississippi's Medicaid program adds coverage for Aerocrine's FeNO testing in …
EON: Enhanced Online News (press release) Asthma is a chronic inflammatory disease of the airways that affects more than 300 million people worldwide, many of whom are children. FeNO is a marker of the underlying airway inflammation associated with asthma, and Aerocrine has developed a method … |
View full post on asthma – Google News
|
Mississippi's Medicaid program adds coverage for Aerocrine's FeNO testing in …
MarketWatch (press release) Asthma is a chronic inflammatory disease of the airways that affects more than 300 million people worldwide, many of whom are children. FeNO is a marker of the underlying airway inflammation associated with asthma, and Aerocrine has developed a method … |
View full post on asthma – Google News
|
Millions Would Be Denied Health-Care Coverage If Reform Law Repealed
NBC4i.com Examples of pre-existing conditions include high blood pressure, heart disease, cancer, asthma and arthritis. The House of Representatives has begun the … |
View full post on asthma – Google News